No Data
No Data
H.C. Wainwright Maintains GH Research(GHRS.US) With Buy Rating, Maintains Target Price $40
Postpartum Depression Pipeline Revealed in 2025 Forecast Report Featuring GH Research, Reunion Neuroscience, Lipocine, and Brii Biosciences
GH Research PLC (GHRS): Among the Best Psychedelic Stocks to Buy in 2025
CCORF Maintains GH Research(GHRS.US) With Buy Rating, Raises Target Price to $35
TD Cowen Maintains GH Research(GHRS.US) With Buy Rating
Promising Trial Results and Strong Financials Justify Buy Rating for GH Research